You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Low-Cost Biological Solution for Reducing Carbon Pollution in Chemical Manufacturing

    SBC: INDUSTRIAL MICROBES INC            Topic: 14NCER1A

    Industrial Microbes is developing a green fermentation platform to replace carbon-emitting petrochemical production with newer methods that build chemicals out of methane and carbon dioxide.Chemical production is a major source of carbon pollution, responsible for 18% of direct industrialemissions. Our innovation is an engineered microbe that can consume carbon dioxide and methane and produce a ch ...

    SBIR Phase II 2016 Environmental Protection Agency
  2. Biofueled Thermoelectric Cookstove

    SBC: HI-Z TECHNOLOGY, INC.            Topic: 15NCER02

    Over 50 million Indian households cook on a bio-mass fire and have unreliable or no electricity but are anxious to purchase an affordable power stove which will provide on-demand power and lighting to their homes. Annually, projected sales of the power stove could save sixteen million trees, reduce cooking fire particulates by 90%, reduce the two million premature deaths caused from indoor air pol ...

    SBIR Phase I 2016 Environmental Protection Agency
  3. High-Efficiency Nutrient Removal and Recovery for Achieving Low Regulatory Limits

    SBC: MICROVI BIOTECH, INC.            Topic: 15NCER05

    Discharge of nutrients (e.g. phosphorus and ammonia) to surface waters can cause eutrophication and the formation of toxic algal blooms, threatening human health and the environment. However, current phosphorus treatment technologies such as chemical precipitation and conventional biological systems can be costly and ineffective to reliably achieve impending effluent regulatory limits of

    SBIR Phase I 2016 Environmental Protection Agency
  4. An Agent-Based Modeling Platform for Environmental Biotechnology

    SBC: MICROVI BIOTECH, INC.            Topic: NIEHS

    DESCRIPTION provided by applicant Hazardous compounds in waters and soils are subject to a complex dynamic web of interactions among physical chemical and biological constituents in the natural environment Computational modeling has been proven indispensable to hazardous substances remediation particularly integrated modeling of pollutant hydrogeological fate and transport For the first t ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Development of An Integrated High Throughput Imaging and Image Analysis Platform for Muscle

    SBC: CytoInformatics LLC            Topic: NIA

    DESCRIPTION provided by applicant There is growing awareness that weakness of muscle is a significant biomedical health issue associated with many different chronic diseases and aging There are a variety of different diseases that affect muscle including muscular dystrophy fibromyalgia cerebral palsy amyotrophic lateral sclerosis and myasthenia gravis each of which carries its own uniqu ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Novel therapy for erosive bone disease

    SBC: Panorama Research Incorporated            Topic: NIA

    DESCRIPTION provided by applicant Osteoclasts OC are key mediators of erosive bone diseases including tumor associated osteolytic lesions as well as rheumatoid arthritis RA other forms of arthritis and osteoporosis Indeed OC are the only cells known to degrade bone Osteoclastogenesis begins with differentiation of monocytes into OC precursor cells OCP which subsequently different ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Anti-RPS23RG1 Nanoantibody as Novel Therapeutic and Research Reagents for Alzheimer’s Disease.

    SBC: ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS            Topic: NIA

    Abstract Alzheimerandapos s disease AD is the most common dementia in the elderly Currently there is no cure for the disease Pathologically AD is characterized by the presence of extracellular amyloid A plaques and intracellular tau neurofibrillary tangles in patientandapos s brain Although being vigorously pursued multiple attempts targeting on A generation clearance have been fail ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Mobile Application to Deliver Personalized Nutrition for the Prevention of Alzheimer s Disease

    SBC: GENBEN LIFESCIENCES CORPORATION            Topic: NIA

    Genben Lifesciences dba GB HealthWatch is a digital health and nutritional genomics company Our mission is to help fight common diet and lifestyle related chronic diseases with precision nutrition and advanced mobile technologies Our company developed the HealthWatch mobile app for tracking dietary intake physical activity and health related symptoms This mobile app has received excell ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Small molecule therapeutics for Alzheimer's Disease

    SBC: CENNA BIOSCIENCES INC            Topic: NIA

    SMALL MOLECULE THERAPEUTICS FOR ALZHEIMERandapos S DISEASE SUMMARY Alzheimerandapos s disease AD is a progressive and fatal neurological disorder that affects approximately one tenth of the population over the age of There is currently no cure for the disease The pathological hallmarks of the disease include the formation and accumulation in the brain of amyloid A Earlier therapeut ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. Multivalent Anti VEGF Conjugates for Sustained Treatment of Diabetic Retinopathy

    SBC: VALITOR, INC.            Topic: N

    Project Summary In approximately million Americans with diabetes were living with the accompanying condition diabetic retinopathy which is the largest cause of blindness among working age individuals in the United States During the progression of DR ischemic neuronal cells in the retina begin to express vascular endothelial growth factor A VEGF A leading to macular edema and retinal ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government